SCHEMBL19652

SCHEMBL19652

CC1C(C)N(C)CCN1C

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10222094 1.00 HTR1A (0.34) HTR1A
SCHEMBL10222090 1.00 HTR1A (0.34) HTR1A
SCHEMBL24035088 1.00 HTR1A (0.34) HTR1A
SCHEMBL16976325 0.85 HTR1A (0.32) HTR1A
SCHEMBL813256 0.78
SCHEMBL21423877 0.78 L3MBTL1 (0.41)
SCHEMBL12059738 0.78 L3MBTL1 (0.41)
SCHEMBL22920524 0.78 L3MBTL1 (0.41)
SCHEMBL21424126 0.78 L3MBTL1 (0.41)
SCHEMBL24452720 0.78 LMNA (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10882874-B2 Vanadium compound ADEKA CORPORATION (JP) 2021-01-05 US disclosed
US-10689589-B2 Cyclic quaternary ammonium salts as fuel or lubricant additives INNOSPEC LIMITED (GB) 2020-06-23 US disclosed
US-20180223203-A1 CYCLIC QUATERNARY AMMONIUM SALTS AS FUEL OR LUBRICANT ADDITIVES INNOSPEC LIMITED (GB) 2018-08-09 US disclosed
US-20180037540-A1 DIAZADIENYL COMPOUND, RAW MATERIAL FOR FORMING THIN FILM, METHOD FOR PRODUCING THIN FILM, AND DIAZADIENE COMPOUND ADEKA CORPORATION (JP) 2018-02-08 US disclosed
US-20170202816-A1 USE OF ANTHELMINTIC AGENTS AGAINST DIROFILARIA IMMITIS INTERVET INC. (US) 2017-07-20 US disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed
US-20110021506-A1 ANTHELMINTIC AGENTS AND THEIR USE INTERVET INTERNATIONAL B.V. (NL) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021506-A1 ANTHELMINTIC AGENTS AND THEIR USE ACHE, ABCB11, MPO HTR1A 3430/4885
US-10689589-B2 Cyclic quaternary ammonium salts as fuel or lubricant additives KAT5, TAF1, KAT2A HTR1A 2031/4885
US-20180223203-A1 CYCLIC QUATERNARY AMMONIUM SALTS AS FUEL OR LUBRICANT ADDITIVES KAT5, HOGA1, HAGH HTR1A 1548/4885
US-10882874-B2 Vanadium compound TERT, ADH1A, TERF2 HTR1A 1950/4885
US-20180037540-A1 DIAZADIENYL COMPOUND, RAW MATERIAL FOR FORMING THIN FILM, METHOD FOR PRODUCING THIN FILM, AND DIAZADIENE COMPOUND DRD4, DRD2, DRD1 HTR1A 584/4885
US-20170202816-A1 USE OF ANTHELMINTIC AGENTS AGAINST DIROFILARIA IMMITIS MPO, DHODH, DHX35 HTR1A 4394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.